Search clinical trials for: Soluble Urokinase Plasminogen Activator Receptor

Total 339 results

University of Thessaly

Completed

SuPAR in Adult Patients With Covid-19 (SPARCOL)

Covid19

Greece
University of Thessaly

Completed

Assessment of the Soluble Urokinase Plasminogen Activator Receptor in Non-cardiac Surgery (SPARSE) (SPARSE)

Surgery--Complications

Greece
Poitiers University Hospital

Completed

Prognostic Value of Soluble Urokinase Plasminogen Activation Receptor (SUPAR) to Rule Out Complications in Patients Admitted in Emergency Department for Acute Abdominal Pain. (GRADIENT)

Mortality | Abdominal Pain | Emergency Department | Soluble Urokinase Plasminogen Activation Receptor

France
Larissa University Hospital

Recruiting

The Role of Ischemia Modified Albumin in Patients With COVID-19

COVID-19

Greece
Second Affiliated Hospital of Nanchang University
Changhai Hospital

Recruiting

Early Lumbar Drainage Combined With Intrathecal Urokinase Injection for Treatment of Severe Aneurysmal SAH (LD-ITUK)

Aneurysmal Subarachnoid Hemorrhage

China
Grifols Therapeutics LLC

Completed

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Acute Peripheral Arterial Occlusion

United States, Peru, Belgium, Bulgaria, Czech Republic, Germany, India, Poland, Romania, Serbia, Slovakia, Spain
General Hospital of Shenyang Military Region

Withdrawn

Intravenous Thrombolysis Registry for Acute Ischemic Stroke in China

Ischemic Stroke

China
Cengiz Gokcek Women's and Children's Hospital

Unknown

Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM (melatonin&PROM)

Preterm Premature Rupture of Membranes

Turkey
The First Affiliated Hospital of Zhengzhou University
Techpool Bio-Pharma Co., Ltd.

Recruiting

Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study

Acute Ischemic Stroke

China
General Hospital of Shenyang Military Region

Completed

Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset (INTRECIS)

Ischemic Stroke

China
Hospital Universitari Vall d'Hebron Research Institute

Completed

Efficacy and Security of Intrapleurally Alteplase vs Urokinase for the Treatment of Complicated Parapneumonic Effusion and Empyema

Pleural Diseases | Pleural Effusion | Empyema, Pleural

Spain
Erasmus Medical Center
DUMAS is sponsored by an unrestricted grant from Thrombolytic Science International...

Completed

Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke (DUMAS)

Ischemic Stroke

Netherlands
Tasly Biopharmaceuticals Co., Ltd.

Completed

Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)

Acute Ischaemic Stroke

China
University of California, San Diego
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke

Stroke

United States
University College, London

Recruiting

Nebulised Rt-PA for ARDS Due to COVID-19 (PACA)

COVID

United Kingdom
Beijing Tsinghua Chang Gung Hospital

Completed

Thrombolysis Endovascular Treatment of Pulmonary Embolism (STEP)

Pulmonary Embolism | Acute Pulmonary Embolism

China
Angde Biotech Pharmaceutical Co., Ltd.

Unknown

Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA) (rPA)

Acute Pulmonary Embolism
Washington University School of Medicine
Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaborators

Completed

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis (ATTRACT)

Venous Thrombosis | Deep Vein Thrombosis | Postphlebitic Syndrome | Venous Thromboembolism | Post Thrombotic Syndrome

United States
Population Health Research Institute
Heart and Stroke Foundation of Canada

Recruiting

Adjunctive, Low-dose tPA in Primary PCI for STEMI (STRIVE)

Myocardial Infarction | Percutaneous Coronary Intervention

Canada
Thomas Jefferson University
Genentech, Inc.

Unknown

Quality of Life After Stroke Using a Telemedicine-based Stroke Network (STROKE TeleQOL)

Stroke

United States
Azienda U.S.L. 1 di Massa e Carrara

Withdrawn

Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism (MONALYSE)

Pulmonary Embolism
University of Washington
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Myocardial Infarction Triage and Intervention Project (MITI)

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
Penumbra Inc.

Completed

Assess the Penumbra System in the Treatment of Acute Stroke (THERAPY)

Ischemic Stroke

United States
M.D. Anderson Cancer Center

Recruiting

Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
General Hospital of Shenyang Military Region

Completed

EXtending the tIme Window of Thrombolysis by ButyphThalide up to 6 Hours After Onset (EXIT-BT)

Stroke, Ischemic

China
Beijing Chao Yang Hospital

Completed

Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China

Thromboembolism | Pulmonary Embolism

China
Assiut University

Unknown

Regisry of the Stroke Patients in Assiut University Hospital

All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex
Hospital de Clinicas de Porto Alegre

Withdrawn

Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke

Stroke

Brazil
University of Cincinnati
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Interventional Management of Stroke (IMS) II Study

Stroke

United States
University of Rijeka

Completed

Neuroinflammatory Response in Patients With ICH and IVH Treated With rtPA

Brain Injuries | Intraventricular Hemorrhage | Hypertensive Intracerebral Hemorrhage
Assiut University
Aswan University Hospital

Completed

TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients (rTPA)

Acute Ischemic Stroke

Egypt
Eastern Regional Medical Center

Recruiting

Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions

Loculated or Non-draining Malignant Pleural Effusions

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Thrombolysis in Myocardial Infarction (TIMI)

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
Sir Charles Gairdner Hospital
The University of Western Australia

Terminated

The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients

Peritoneal Dialysis | Peritoneal Dialysis, Continuous Ambulatory

Australia
National Institutes of Health Clinical Center (CC)

Completed

Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins

Thrombosis

United States
Fundació Institut de Recerca de l'Hospital de la...

Completed

Sonothrombolysis Potentiated by Microbubbles for Acute Ischemic Stroke

Cerebrovascular Stroke

Spain
Yale University

Withdrawn

The Safety and Efficacy of Fibrinolysis in Patients With an Indwelling Pleural Catheter for Multi-loculated Malignant Pleural Effusion.

Pleural Effusion | Cancer, Lung
Mazandaran University of Medical Sciences

Completed

Thrombolysis Outcome in Ischemic Stroke (TOSSI)

Mortality | Stroke, Acute | Thrombolytic Therapy | Alteplase

Iran, Islamic Republic of
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Thrombolysis in Myocardial Ischemia Trial (TIMI III)

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Angina Pectoris
Johns Hopkins University

Completed

Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage

Cerebral Hemorrhage

United States
Neuroscience Trials Australia
Melbourne Health; University of Melbourne; Commonwealth Scientific and Industrial... and other collaborators

Completed

Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND)

Stroke

Australia, Finland, New Zealand
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Completed

Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis (TROIA)

Prosthetic Valve Thrombosis

Turkey
Neuroscience Trials Australia
China Medical University Hospital

Completed

EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International) (EXTEND)

Stroke

Taiwan
Kyorin University

Completed

Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm

Submacular Hemorrhage | Ruptured Retinal Arterial Macro Aneurysms

Japan
Niguarda Hospital

Completed

Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS)

Stroke | Cerebrovascular Accident

Italy
Second Affiliated Hospital, School of Medicine,...

Recruiting

EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs

Stroke, Acute Ischemic

China
Tulane University

Completed

Fibrinolysis Compared to Thoracoscopy for Pleural Infection

Pleural Diseases | Pleural Infection | Empyema | Parapneumonic Effusion

United States
Neuroscience Trials Australia

Terminated

Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial (EXTEND-IA)

Ischemic Stroke

Australia, New Zealand
South West Sydney Local Health District

Recruiting

Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure (VETtiPAT-ARF)

Acute Respiratory Failure | Hypercoagulability | Fibrinolysis Shutdown

Australia
Melbourne Health

Completed

Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (TASTEa)

Stroke, Acute, Stroke Ischemic

Australia

Search clinical trials for: Soluble Urokinase Plasminogen Activator Receptor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations